Pelvic irradiation-induced eosinophilia is correlated to prognosis of cervical cancer patients and transient elevation of serum interleukin 5 level

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 23, Issue 5, 2005, Pages 317-321

  Yamazaki, Hideya ^a   Inoue, Takehiro ^b   Tanaka, Eiichi ^b   Isohashi, Fumiaki ^b   Koizumi, Masahiko ^a   Shuo, Xing ^b   Nakamura, Hironobu ^b   Inoue, Toshihiko ^b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical cancer; Eosinophilia; Interleukin 5; Radiotherapy

Indexed keywords

INTERLEUKIN 5;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; PROGNOSIS; SURVIVAL RATE; UTERINE CERVIX CANCER; UTERUS CANCER; VAGINA CANCER;

ADULT; AGED; ANALYSIS OF VARIANCE; BRACHYTHERAPY; CARCINOMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INTERLEUKIN-5; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS; VAGINAL NEOPLASMS;

EID: 24644499567     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood, 15: 3101-3109, 1992.
2. Radhakrishna Pillai M, Balaram P, Bindu S, Hareendran NK, Padmanabhan TK, Nair MK. Radiation associated eosinophilia and monocytosis in carcinoma of the uterine cervix: a simple reliable clinical and prognostic indicator. Neoplasm, 37: 91-96, 1990.
3. Kopf M, Brombacher F, Hodgkin PD, et al. IL-5 deficient mice have a developmental defect on CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity, 4: 15-24, 1996.
4. Wierenga EA, Backx B, Snoek M, Koenderman L, Kapsenberg ML. Relative contributions of human types 1 and 2 T-helper cell-derived eosinophilotrophic cytokines to development of eosinophilia. Blood, 82: 1471-1479, 1993.
5. 137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix. Brachytherapy, 2: 85-90, 2003.
6. Ghossein NA, Bosworth JL, Stacey P, Muggia FM, Krishnaswamy V. Radiation-related eosinophilia: Correlation with delayed hypersensitivity, lymphocyte count, and survival in patients treated by curative radiotherapy. Radiology, 111: 413-417, 1975.
7. Dalal BI, Das KC, Dutta TK, Malakar K. Local and systemic eosinopilia in patients with carcinoma of the uterine cervix undergoing radiation therapy: correlation with radiation response. Clin Oncol (R Coll Radiol), 4: 18-21, 1992.
8. Murohashi I, Gomi H, Nakano T, et al. Relationship of bone marrow dose to eosinophilia following radiotherapy: a study of patients with breast, lung, cervical and ovarian cancer. Nippon Ketsueki Gakkai Zasshi, 49: 1368-1376, 1986.
9. Limaye AP, Abrams JS, Silver JE, Ottesen EA, Nutman T. Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J Exp Med, 172: 399-402, 1990.
10. Lu-Hasselmann J, Messer G, van Beuningen D, Kind P, Peter RU. Transcriptional regulation of the human IL5 gene by ionizing radiation in Jurkat T cells: evidence for repression by an NF-AT-like element. Radiat Res, 148: 531-542, 1997.
11. Pastnak A, Jansa P. Local eosinophilia in stroma of tumors related to prognosis. Neoplasma, 31: 323-326, 1984.
12. Iwasaki K, Torisu M, Fujimura T. Malignant tumor and eosinophils. I. Prognostic significance in gastric cancer. Cancer, 58: 1986, 1321-1327.
13. Pretlow TP, Keith EF, Cryar AK, et al. Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. Cancer Res, 43: 2997-3000, 1983.
14. Rivoltini L, Viggiano V, Spinazze S, et al. In vitro antitumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2; role of interleukin 5. Int J Cancer, 54: 8-15, 1993.